Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
European Cardiology|January 15, 2020
Expert Opinion: Meditation and Cardiovascular Health: What is the Link?Sebastian Schnaubelt, Andreas Hammer, Lorenz Koller, et al.
International Journal of Cardiology|November 17, 2016
Long-term outcome and risk prediction in patients suffering acute myocardial infarction complicated by post-infarction cardiac rupturePatrick Sulzgruber, Feras El-Hamid, Lorenz Koller, et al.
Thrombosis and Haemostasis|July 15, 2016
Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failureLorenz Koller, Philipp Hohensinner, Patrick Sulzgruber, et al.
European Journal of Clinical Investigation|February 13, 2013
Platelet count predicts cardiovascular mortality in very elderly patients with myocardial infarctionGeorg Goliasch, Stefan Forster, Feras El-Hamid, et al.
Journal of Clinical Medicine|January 21, 2023
The Epidemiology of Pre-Hospital EMS Treatment of Geriatric Patients in the City of Vienna-An OverviewMario Krammel, Valentin Drahohs, Thomas Hamp, et al.
Journal of Cardiovascular Development and Disease|May 26, 2023
Differences in Automated External Defibrillator Types in Out-of-Hospital Cardiac Arrest Treated by Police First RespondersMario Krammel, Jakob Eichelter, Constantin Gatterer, et al.
European Heart Journal Open|August 3, 2022
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndromeNiema Kazem, Felix Hofer, Lorenz Koller, et al.
Resuscitation|December 3, 2014
Survivors of cardiac arrest with good neurological outcome show considerable impairments of memory functioningPatrick Sulzgruber, Andreas Kliegel, Cosima Wandaller, et al.
Resuscitation|February 8, 2022
Very long-term survivors of in-hospital and out-of-hospital cardiac arrest show considerable impairment of daily lifeSebastian Schnaubelt, Florian B Mayr, Heidrun Losert, et al.
Cardiovascular Drugs and Therapy|March 5, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery DiseaseFelix Hofer, Niema Kazem, Ronny Schweitzer, et al.
Pageof 11